Welcome Guest
Home > Clinical Lung Cancer > Volume 7 | Supplement 1

Table of Contents

Volume 7 | Supplement 1

Publication Date: September 2005
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Introduction
Page Number of this Article in the Print Version
S4-S5		 Emerging Novel Agents with Utility in Non-Small-Cell Lung Cancer
Chandra P. Belani
  • Abstract
  • No Access
  • Add to Cart
Contributions
Page Number of this Article in the Print Version
S6-S12		 Activity of Novel Cytotoxic Agents in Lung Cancer: Epothilones and Topoisomerase I Inhibitors
Heather A. Wakelee, Branimir I. Sikic
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S13-S18		 Current Status of Mammalian Target of Rapamycin Inhibitors in Lung Cancer
Carlos Gómez-Martín, Belen Rubio-Viqueira, Manuel Hidalgo
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S19-S30		 Histone Deacetylase Inhibitors: Emerging Anticancer Therapeutic Agents
Rebecca Kristeleit, Peter Fong, G. Wynne Aherne, Johann de Bono
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S31-S38		 Targeting Angiogenesis with Vascular Endothelial Growth Factor Receptor Small-Molecule Inhibitors: Novel Agents with Potential in Lung Cancer
Heather A. Wakelee, Joan H. Schiller
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
S39-S44		 Targeting Multiple Signal Transduction Pathways in Lung Cancer
Alex A. Adjei
  • Abstract
  • No Access
  • Add to Cart